HighTower Advisors’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-16,204
Closed -$1.22M 3904
2026
Q1
$1.22M Buy
16,204
+3,310
+26% +$249K ﹤0.01% 2041
2025
Q4
$960K Sell
12,894
-1,168
-8% -$85.3K ﹤0.01% 2156
2025
Q3
$949K Sell
14,062
-545
-4% -$36.2K ﹤0.01% 2135
2025
Q2
$952K Sell
14,607
-1,177
-7% -$70.5K ﹤0.01% 2045
2025
Q1
$975K Sell
15,784
-784
-5% -$51.9K ﹤0.01% 1978
2024
Q4
$1.19M Sell
16,568
-6,035
-27% -$471K ﹤0.01% 1853
2024
Q3
$1.83M Buy
22,603
+2,012
+10% +$161K ﹤0.01% 1563
2024
Q2
$1.52M Buy
20,591
+340
+2% +$25.5K ﹤0.01% 1602
2024
Q1
$1.57M Buy
20,251
+1,645
+9% +$122K ﹤0.01% 1550
2023
Q4
$1.34M Sell
18,606
-4,023
-18% -$280K ﹤0.01% 1684
2023
Q3
$1.56M Sell
22,629
-4,940
-18% -$373K ﹤0.01% 1517
2023
Q2
$2.22M Buy
27,569
+10,858
+65% +$887K ﹤0.01% 1296
2023
Q1
$1.33M Sell
16,711
-5,097
-23% -$410K ﹤0.01% 1522
2022
Q4
$1.62M Buy
21,808
+2,600
+14% +$185K ﹤0.01% 1398
2022
Q3
$1.24M Sell
19,208
-6,850
-26% -$474K ﹤0.01% 1491
2022
Q2
$1.81M Sell
26,058
-6,113
-19% -$454K ﹤0.01% 1319
2022
Q1
$2.47M Sell
32,171
-557
-2% -$40.1K 0.01% 1250
2021
Q4
$2.51M Sell
32,728
-42,398
-56% -$3.12M 0.01% 1235
2021
Q3
$5.55M Buy
75,126
+28,612
+62% +$2.15M 0.01% 775
2021
Q2
$3.1M Buy
46,514
+15,536
+50% +$1.04M 0.01% 991
2021
Q1
$2.3M Buy
30,978
+20,885
+207% +$1.59M 0.01% 1064
2020
Q4
$738K Buy
10,093
+152
+2% +$10.7K ﹤0.01% 1428
2020
Q3
$664K Buy
9,941
+1,076
+12% +$68.1K ﹤0.01% 1432
2020
Q2
$507K Buy
8,865
+1,039
+13% +$51K ﹤0.01% 1449
2020
Q1
$275K Sell
7,826
-417
-5% -$19.9K ﹤0.01% 1618
2019
Q4
$431K Buy
8,243
+1,122
+16% +$55.9K ﹤0.01% 1512
2019
Q3
$359K Buy
7,121
+478
+7% +$23.5K ﹤0.01% 1681
2019
Q2
$323K Sell
6,643
-25
-0.4% -$1.16K ﹤0.01% 1756
2019
Q1
$326K Sell
6,668
-1,855
-22% -$83.6K ﹤0.01% 1683
2018
Q4
$355K Buy
8,523
+2,525
+42% +$104K ﹤0.01% 1528
2018
Q3
$248K Buy
+5,998
New +$242K ﹤0.01% 1828
2018
Q2
Sell
-14,446
Closed -$542K 2307
2018
Q1
$542K Sell
14,446
-23,225
-62% -$938K ﹤0.01% 1376
2017
Q4
$1.61M Sell
37,671
-6,408
-15% -$256K 0.01% 894
2017
Q3
$1.62M Buy
44,079
+18,909
+75% +$763K 0.01% 900
2017
Q2
$1.13M Buy
25,170
+14,759
+142% +$651K 0.01% 1001
2017
Q1
$444K Sell
10,411
-1,916
-16% -$78.1K ﹤0.01% 1381
2016
Q4
$495K Sell
12,327
-142
-1% -$5.48K 0.01% 1256
2016
Q3
$485K Buy
12,469
+4,863
+64% +$184K 0.01% 1260
2016
Q2
$265K Sell
7,606
-2,109
-22% -$73K ﹤0.01% 1373
2016
Q1
$337K Buy
9,715
+3,065
+46% +$107K ﹤0.01% 1562
2015
Q4
$258K Buy
+6,650
New +$259K ﹤0.01% 1634
2014
Q2
Sell
-55,469
Closed -$1.19M 1650
2014
Q1
$1.19M Buy
55,469
+8,643
+18% +$186K 0.02% 682
2013
Q4
$1.05M Buy
+46,826
New +$1.03M 0.02% 679

Other funds holding HOLX

HighTower Advisors's HOLX Position: Q2 2026 in Review

HighTower Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 16,204 shares — an estimated $1.22M sold.

HighTower Advisors first reported a position in HOLX in Q4 2013 and held it in 43 quarters. The position peaked at $5.55M in Q3 2021. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • HighTower Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • HighTower Advisors sold 16,204 Hologic shares in Q2 2026, an estimated $1.22M.
  • HighTower Advisors first reported a position in Hologic in Q4 2013 and held it in 43 quarters.
  • HighTower Advisors's Hologic position peaked at $5.55M in Q3 2021.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.